Elutia Analyst Price Targets

Wall Street analyst price targets and consensus rating for Elutia (ELUT).

Price Target Range — 7 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingOverweight# Analysts2Avg. Consensus PT$7Upside to Avg. PT+764.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 10, 2025	Lake Street	Frank Takkinen	PT Cut	Buy	$8→$6
May 9, 2025	Lake Street	Frank Takkinen	PT Cut	Buy	$10→$8
Mar 7, 2025	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$8
Nov 15, 2024	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$10
Sep 6, 2024	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$10
Aug 8, 2024	Cantor Fitzgerald	Ross Osborn	PT Cut	Overweight	$11→$10
Jun 21, 2024	Lake Street	Frank Takkinen	PT Raise	Buy	$5→$10
Jun 20, 2024	Cantor Fitzgerald	Ross Osborn	PT Raise	Overweight	$5→$11
Jun 18, 2024	Cantor Fitzgerald	Ross Osborn	PT Raise	Overweight	$5→$11
May 10, 2024	Cantor Fitzgerald	Ross Osborn	PT Cut	Overweight	$6→$5
Nov 14, 2023	Cantor Fitzgerald	Ross Osborn	PT Cut	Overweight	$8→$6

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $6

Lake Street analyst Frank Takkinen maintains Elutia (NASDAQ:ELUT) with a Buy and lowers the price target from $8 to $6.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $8

Lake Street analyst Frank Takkinen maintains Elutia (NASDAQ:ELUT) with a Buy and lowers the price target from $10 to $8.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $8 Price Target

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:ELUT) with a Overweight and maintains $8 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:ELUT) with a Overweight and maintains $10 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:ELUT) with a Overweight and maintains $10 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $10

Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and lowers the price target from $11 to $10.

Benzinga Newsdesk

Elutia Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Elutia Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $6

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $8

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $8 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PRO
Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $10

People Also Watch

People Also Watch

Elutia Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Elutia Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLake Street Maintains Buy on Elutia, Lowers Price Target to $6

PROLake Street Maintains Buy on Elutia, Lowers Price Target to $8

PROCantor Fitzgerald Reiterates Overweight on Elutia, Maintains $8 Price Target

PROCantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PROCantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PROCantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $10

People Also Watch

People Also Watch

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $6

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $8

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $8 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PRO
Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $10